Epilepsy Research
Volume 24, Issue 1 , Pages 9-18 , May 1996

Competitive NMDA receptor antagonists do not block cholinergic kindling with carbachol

  • D. Saucier

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 (519) 679 2067; fax: +1 (519) 661 3961.
    • Department of Psychology, University of Western Ontario, London, Ont. N6A 5C, Canada
    • ,
  • D.P. Cain

      Affiliations

    • Graduate Program in Neuroscience, University of Western Ontario, London, Ont. N6A 5C, Canada

Received 25 June 1995 ,Revised 14 December 1995 ,Accepted 15 December 1995.

References 

  1. Arnold PS, Racine RJ, Wise RA. Effects of atropine, reserpine, 6-hydroxydopamine and handling on seizure development in the rat. Exp. Neurol. 1973;40:457–470
  2. Burchfiel JL, Duchowny MS, Duffy FH. Neuronal supersensitivity to acetylcholine induced by kindling in the rat hippocampus. Science. 1979;204:1096–1098
  3. Cain DP. Bidirectional transfer of electrical and carbachol kindling. Brain Res. 1983;260:135–138
  4. Cain DP. Excitatory neurotransmitter in kindling: excitatory amino acid, cholinergic, and opiate mechanisms. Neurosci. Biobehav. Rev. 1989;13:269–276
  5. Cain DP, Boon F, Corcoran ME. Involvement of multiple opiate receptors in opioid kindling. Brain Res. 1990;517:236–244 1990
  6. Cain DP, Boon F, Hargreaves EL. Evidence for different pharmacological contributions to long-term potentiation and to kindling and kindling-induced potentiation: role of NMDA and urethane-sensitive mechanisms. Exp. Neurol. 1992;116:330–338
  7. Cain DP, Desborough KA, McKitrick DJ. Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling. Exp. Neurol. 1988;100:179–187
  8. Croucher MJ, Bradford HF. Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdala. Brain Res. 1989;501:58–65
  9. Croucher MJ, Bradford HF. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala. Brain Res. 1990;506:349–352
  10. Croucher MJ, Collins JF, Meldrum BS. Anticonvulsant action of excitatory amino acids. Science. 1982;218:899–901
  11. Dennison Z, Cain DP. Retardation of amygdaloid kindling in the rat by the excitatory amino acid antagonist kynurenic acid. Synapse. 1989;4:171–173
  12. Dingledine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends. Pharmacol. Sci. Spec. Rep. 1990;49–53
  13. Ferkany JW, Hamilton GS, Patch RJ, Huang Z, Borosky SA, Bednar DL, et al. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5(1,2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-d-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 1993;264:256–264
  14. Fukuda H, Tatsuya T, Kaijima M, Nakai H, Yonemasu Y. Quisqualic acid-induced hippocampal seizures in unanesthetized cats. Neurosci. Lett. 1985;59:53–59
  15. Gilbert ME. The NMDA-receptor antagonist, MK-801 suppresses limbic kindling and kindled seizures. Brain Res. 1988;463:90–99
  16. Gilbert ME. The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling. Epilepsy Res. 1994;17:145–156
  17. Gilbert ME, Mack CM. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat. Brain Res. 1990;519:89–96
  18. Herron CE, Williamson R, Collingridge GL. A selective N-methyl-d-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci. Lett. 1985;61:255–260
  19. Holmes KH, Bilkey DK, Laverty R, Goddard GV. The N-methyl-d-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures. Brain Res. 1990;506:227–235
  20. Loscher W, Honack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-d-aspartic acid receptor antagonist, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 1991;256:432–440
  21. Martin D, McNamara JO, Nadler JV. Kindling enhances sensitivity of CA3 hippocampal pyramidal cells to NMDA. J. Neurosci. 1992;12:1928–1935
  22. McNamara JO, Morrisett R, Nadler JV. Recent advances in understanding mechanisms of the kindling model. In: 2nd Ed..  Chavel P,  Delgado-Escueta AV editor. Advances in Neurology. Vol. 57:New York, NY: Raven Press; 1992;p. 555–560
  23. McNamara JO, Russell RD, Rigsbee L, Bonhaus DW. Anticonvulsant and antiepileptiform actions of MK-801 in kindling and electroshock models. Neuropharmacology. 1988;27:563–568
  24. Millan MH, Meldrum BS, Faingold C. Induction of audiogenic seizure susceptibility by focal infusion of excitant amino acid or bicuculline into the inferior colliculus of normal rats. Exp. Neurol. 1986;91:634–639
  25. Monaghan DT. Anatomical organization and apparent heterogeneity of NMDA receptors. In:  Kozikowski AP editors. Neurobiology of the NMDA Receptor: From Chemistry to the Clinic. New York, NY: VCH Publishers; 1991;p. 149–171
  26. Monyer H, Burnashev N, Laurie D, Sakmann B, Seeberg P. Development and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12:529–540
  27. Mori N, Wada J. Bidirectional transfer of kindling induced between excitatory amino acids and electrical stimulation. Brain Res. 1987;425:45–48
  28. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Ed.. Sydney, Australia: Academic Press; 1986;
  29. Pellegrino LJ, Pellegrino AS, Cushman AJ. In: 2nd Ed.. A Stereotaxic Atlas of the Rat Brain. New York, NY: Plenum Press; 1979;
  30. Peterson DW, Collins JF, Bradford HF. The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists. Brain Res. 1983;275:169–172
  31. Peterson DW, Collins JF, Bradford HF. Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures. Brain Res. 1984;311:176–180
  32. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. Clin. Neurophysiol. 1972;32:281–294
  33. Sato K, Morimoto K, Okamoto M. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Brain Res. 1988;463:12–20
  34. Saucier D, Cain DP. Spatial learning without NMDA-dependent long term potentiation. Nature. 1995;378:186–188
  35. Saucier, D., Hargreaves, E.L., Boon, F., Vanderwolf, C.H. and Cain, D.P., Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits, Behav. Neurosci., in press.
  36. Simalowski A. Excitatory effect of intrahippocampal injection of glutamic acid on rabbit EEG. J. Neural Trans. 1983;58:205–211
  37. Stasheff SF, Anderson WW, Clark S, Wilson WA. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science. 1989;245:648–651
  38. Stelzer A, Slater NT, Galvan M, Bruggencate G. N-methyl-d-aspartate receptors and hippocampal kindling. In:  Hicks TP, et al. editor. Excitatory Amino Acid Transmission. New York, NY: Alan R. Liss; 1987;p. 71–74
  39. Trommer BL, Pasternak JF. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats. Dev. Brain Res. 1990;53:248–252
  40. Vosu H, Wise RA. Cholinergic seizure kindling in the rat: comparison of caudate, amygdala and hippocampus. Behav. Biol. 1975;13:491–495
  41. Wasterlain CG, Jonec V. Cholinergic kindling of the amygdala requires the activation of muscarinic receptors. Exp. Neurol. 1981;73:595–599
  42. Wasterlain CG, Jonec V. Chemical kindling by muscarinic amygdaloid stimulation in the rat. Brain Res. 1983;271:311–323
  43. Westerberg V, Corcoran ME. Antagonism of central but not peripheral cholinergic receptors retards amygdala kindling in rats. Exp. Neurol. 1987;95:206–1994
  44. Willetts J, Clissold DB, Hartman TL, Brandsgaard RR, Hamilton GS, Ferkany JW. Behavioral pharmacology of NPC 17742, a competitive N-methyl-d-aspartate (NMDA) antagonist. J. Pharmacol. Exp. Ther. 1993;265:1055–1062
  45. Young NA, Lewis SJ, Vajda F, Beart P. Effects of NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat. Exp. Neurol. 1989;103:199–202

PII: 0920-1211(95)00106-9

Epilepsy Research
Volume 24, Issue 1 , Pages 9-18 , May 1996

Article Tools